These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15550378)

  • 1. Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells.
    Peng B; Hodge DR; Thomas SB; Cherry JM; Munroe DJ; Pompeia C; Xiao W; Farrar WL
    J Biol Chem; 2005 Feb; 280(6):4182-7. PubMed ID: 15550378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA hypermethylation and partial gene silencing of human thymine- DNA glycosylase in multiple myeloma cell lines.
    Peng B; Hurt EM; Hodge DR; Thomas SB; Farrar WL
    Epigenetics; 2006; 1(3):138-45. PubMed ID: 17965616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation.
    Hodge DR; Peng B; Cherry JC; Hurt EM; Fox SD; Kelley JA; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jun; 65(11):4673-82. PubMed ID: 15930285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line.
    Pompeia C; Hodge DR; Plass C; Wu YZ; Marquez VE; Kelley JA; Farrar WL
    Cancer Res; 2004 May; 64(10):3465-73. PubMed ID: 15150099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
    Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
    Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents.
    Bearzatto A; Szadkowski M; Macpherson P; Jiricny J; Karran P
    Cancer Res; 2000 Jun; 60(12):3262-70. PubMed ID: 10866320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation.
    Hodge DR; Peng B; Pompeia C; Thomas S; Cho E; Clausen PA; Marquez VE; Farrar WL
    Cancer Biol Ther; 2005 May; 4(5):585-92. PubMed ID: 15908783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
    Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H
    Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
    Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
    Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
    Cheng JC; Matsen CB; Gonzales FA; Ye W; Greer S; Marquez VE; Jones PA; Selker EU
    J Natl Cancer Inst; 2003 Mar; 95(5):399-409. PubMed ID: 12618505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-steady-state binding of damaged DNA by XPC-hHR23B reveals a kinetic mechanism for damage discrimination.
    Trego KS; Turchi JJ
    Biochemistry; 2006 Feb; 45(6):1961-9. PubMed ID: 16460043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
    Tshuikina M; Jernberg-Wiklund H; Nilsson K; Oberg F
    Exp Hematol; 2008 Dec; 36(12):1673-1681. PubMed ID: 18922617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable binding of human XPC complex to irradiated DNA confers strong discrimination for damaged sites.
    Batty D; Rapic'-Otrin V; Levine AS; Wood RD
    J Mol Biol; 2000 Jul; 300(2):275-90. PubMed ID: 10873465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma.
    Peng L; Yang Z; Tan C; Ren G; Chen J
    Mol Med Rep; 2013 Mar; 7(3):1055-61. PubMed ID: 23358566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.
    Dote H; Cerna D; Burgan WE; Carter DJ; Cerra MA; Hollingshead MG; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2005 Jun; 11(12):4571-9. PubMed ID: 15958643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.
    Shen L; Kondo Y; Ahmed S; Boumber Y; Konishi K; Guo Y; Chen X; Vilaythong JN; Issa JP
    Cancer Res; 2007 Dec; 67(23):11335-43. PubMed ID: 18056460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.